In collaboration with our partners at Sermo, our Advanced Data Science and Artificial Intelligence solutions played a crucial role in uncovering previously unseen intelligence about GLP-1 and...
Talking Medicines Blogs
Blog Posts
View All Blogs
See More →
Talking Medicines Blog Posts
See More →
Blog Categories
Talking Medicines Blogs
Unveiling the Future of Market Research: A Paradigm Shift for New York Agencies
In the bustling landscape of New York's agency world, staying ahead of the curve is not just a goal—it's a necessity. In an era where consumer preferences evolve rapidly and industries undergo...
Harnessing AI Intelligence to Inform Creative Strategy: A Look Into Drug-GPT’s Audience Analyzer
Understanding the nuanced perspectives of both patients and healthcare professionals (HCPs) is crucial for developing effective and empathetic communication strategies. A recent case study...
Optimize Brand Planning with Drug-GPT
As we enter the start of brand planning season, Healthcare Marketing Strategists are under immense pressure to develop effective, data-driven strategies. The need for rapid, precise data analysis is...
4 Reasons Why Talking Medicines Drug-GPT Can Help Healthcare Marketing Agencies Win and Execute RFPs
In the highly competitive landscape of healthcare marketing, securing new clients through RFPs (Requests for Proposals) is essential. Here’s how leveraging Talking Medicines Drug-GPT can support...
The Opportunities for AI tools in a Data Driven Healthcare Environment
Talking Medicines co-founder Scott Crae was invited by the Ethical Medicines Industry Group (EMIG) to present on: ‘The Opportunities for AI tools in a Data Driven Healthcare Environment.’ EMIG is...
Understanding Advanced AI & Data Science Analysis in Healthcare Marketing Strategy
In healthcare marketing, standing out requires more than traditional tactics; it demands innovation and precision. According to a Forbes Advisor survey, 56% of businesses are using AI to improve...
Expanding into the US Marketing with Industry Expert Phil Crowley
Introduction: Expanding into the U.S. market is a thrilling prospect for tech startups but comes with its share of challenges, particularly in understanding and navigating the complex U.S. legal...
Unveiling the GLP-1 Drug Revolution: Insights from Unstructured Conversational Data
In the landscape of healthcare, the ever-evolving landscape of drug development and patient engagement requires continuous adaptation and innovation. Recently, the GLP-1 drugs, hailed as a...
GLP-1 Agonists: A New Era in Treating Obesity and Type 2 Diabetes
The World Health Organization (WHO) has sounded the alarm on the global obesity crisis, labelling it an "epidemic" that's spiraling out of control. By 2030, it's estimated that over 1 billion people...
From Manual Data Extraction to Strategic Insights: Leveraging Drug-GPT in Healthcare Marketing
Navigating the complexities of Healthcare Marketing isn't merely about managing vast amounts of data—it's about interpreting it in a meaningful way across various healthcare voices including...
Unlock Millions of Curated Healthcare Conversations with Drug-GPT & Socialgist
In a digital era where countless conversations unfold online every minute, deciphering the intricate network of dialogues within the healthcare domain has become essential, especially for Healthcare...